R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
ACTIVE_NOT_RECRUITING
Status
Conditions
- Recurrent B-Cell Non-Hodgkin Lymphoma
- Recurrent Diffuse Large B-Cell Lymphoma
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Recurrent Transformed Non-Hodgkin Lymphoma
- Refractory B-Cell Non-Hodgkin Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Refractory Transformed Non-Hodgkin Lymphoma
Interventions
- DRUG: Carboplatin
- DRUG: Etoposide
- DRUG: Ifosfamide
- OTHER: Laboratory Biomarker Analysis
- DRUG: Lenalidomide
- BIOLOGICAL: Rituximab
Sponsor
Academic and Community Cancer Research United
Collaborators